Girl, eight, with rare brain disorder in pioneering UCL stem cell research – Evening Standard
Evening Standard |
Girl, eight, with rare brain disorder in pioneering UCL stem cell research
Evening Standard A girl of eight whose rare brain disorder is likely to lead to her death when she is in her teens is taking part in pioneering stem cell research in a bid to save others with same condition. Lily Harriss’s skin cells will first be turned into stem … |
|
Synthetic Biology Market Status & Forecast to 2022
Medgadget (blog) Big Market Research recently added a report titled, ”Global Synthetic Biology Market Status 2011-2022 Market Historical and Forecasts Professional Market Research Report” The report takes a closer look at the key parameters of the SYNTHETIC BIOLOGY … |
New York Daily News |
Why the TRAPPIST-1 exoplanet discovery matters: The co-creator of ‘The Expanse’ on the importance of reaching for …
New York Daily News The technologies that might bring us across that immense void — generation ships, suspended animation, warp drives — don’t exist. Yet. Like the building of medieval cathedrals where the generation that laid the foundations would not live to see the … |
Oncology Nursing News |
FDA approves Revlimid for myeloma maintenance after stem cell transplant
Healio Lenalidomide (Revlimid, Celgene) is the only FDA–approved treatment for maintenance after autologous HSCT. “Autologous stem cell transplant after induction therapy is part of the continuum of care for transplant-eligible multiple myeloma patients … FDA Expands Indication for REVLIMID® (lenalidomide) as a Maintenance Treatment for Patients with Multiple Myeloma …Yahoo Finance Maintenance Revlimid Gains FDA Approval for Multiple MyelomaCuretoday.com FDA Approves Maintenance Lenalidomide for MyelomaOncLive |